×

Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device

  • US 8,435,550 B2
  • Filed: 08/13/2008
  • Issued: 05/07/2013
  • Est. Priority Date: 12/16/2002
  • Status: Expired due to Fees
First Claim
Patent Images

1. A drug-delivery system, comprising:

  • at least 100 μ

    g of everolimus; and

    clobetasol, such that the amount of everolimus by weight is at least 10 times more than clobetasol.

View all claims
  • 2 Assignments
Timeline View
Assignment View
    ×
    ×